MEDGEN INC

As of September 30, 2008, MEDGEN INC carries a market capitalization of 68,151.65, placing it among publicly traded companies globally. Its enterprise value stands at 6.30M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2008, MEDGEN INC has 22.72M shares outstanding.

These figures are as of September 30, 2008. The price-to-sales ratio is 0.02, and the price-to-book ratio stands at 0.00.

These figures are as of September 30, 2008. The EV/Sales ratio of 5.69 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 6.30M versus a market cap of 68,151.65, with the gap driven by net debt and cash on the balance sheet.

As of September 30, 2008, MEDGEN INC maintains a current ratio of 0.00, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended September 30, 2008. Return on assets (ROA) is negative at -670,809.59, reflecting losses generated across the asset base. The company generates approximately 164,069.04 in revenue per employee across its workforce of 6.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 10.37 indicates how many times MEDGEN INC sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended September 30, 2008, MEDGEN INC generated 1.11M in revenue and converted that into -6.06B in net income, yielding earnings per share of -978.55. EBITDA reached -1.76M, while operating income came in at -1.76M.

As of September 30, 2008, MEDGEN INC holds 62,137.00 in cash and equivalents against 6.30M in total debt, resulting in a net debt position of 6.24M. Total book value stands at -6.08B, with working capital of -6.08B providing operational flexibility.

MEDGEN INC produced -1.70M in operating cash flow over the twelve months ended September 30, 2008. After subtracting -70,249.00 in capital expenditures, free cash flow totaled -1.77M - equivalent to -0.29 per share.

Over the twelve months ended September 30, 2008, MEDGEN INC posted a gross margin of 24.43, reflecting its pricing power and cost economics. The operating margin of -159.30 and net profit margin of -546,928.31 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2008. Free cash flow yield is negative at -9,506.53: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -847.29, meaning MEDGEN INC raised more capital through share issuance and new debt than it returned via dividends and buybacks.

MEDGEN INC's most recent stock split took place on August 4, 2010 with a 30:1 split ratio.

As of September 30, 2008, MEDGEN INC has an Altman Z-Score of -67,675.04, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.